The PE Ratio as of March 2026 (TTM) for NKGen Biotech, Inc. Common Stock (NKGN) is -0.11

According to NKGen Biotech, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of 224.13% compared to the average of -0.03 of the last 4 quarters.

NKGen Biotech, Inc. Common Stock (NKGN) Historical PE Ratio (quarterly & annually)

How has NKGN PE Ratio performed in the past?

The mean historical PE Ratio of NKGen Biotech, Inc. Common Stock over the last ten years is -2.70. The current -0.11 PE Ratio has changed 308.11% with respect to the historical average. Over the past ten years (40 quarters), NKGN's PE Ratio was at its highest in in the March 2022 quarter at 15.29. The PE Ratio was at its lowest in in the March 2021 quarter at -858.40.

NKGen Biotech, Inc. Common Stock (NKGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NKGen Biotech, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NKGen Biotech, Inc. Common Stock (NKGN) Average PE Ratio

How has NKGN PE Ratio performed in the past?

The current PE Ratio of NKGen Biotech, Inc. Common Stock (NKGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NKGen Biotech, Inc. Common Stock (NKGN) PE Ratio vs. Peers

How is NKGN’s PE Ratio compared to its peers?

NKGen Biotech, Inc. Common Stock’s PE Ratio is less than Windtree Therapeutics, Inc. (-0.00), less than PMGC Holdings Inc. (-0.01), greater than BriaCell Therapeutics Corp. Warrant (-0.25), greater than Protagenic Therapeutics, Inc. (-0.25), greater than XORTX Therapeutics Inc. (-0.91), greater than Moolec Science S.A. (-4.90), greater than Virax Biolabs Group Limited (-0.15), greater than Dermata Therapeutics, Inc. (-0.17), greater than NewcelX Ltd. (-0.44), greater than Avenue Therapeutics, Inc. (-0.25),

Build a custom stock screener for NKGen Biotech, Inc. Common Stock (NKGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NKGen Biotech, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NKGen Biotech, Inc. Common Stock (NKGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NKGen Biotech, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.